Silo Pharma (SILO) Shares Issued (2023 - 2026)

Silo Pharma (SILO) posted Shares Issued of $71183.0 for Q1 2026, down 86.39% sequentially from $522850.0 in Q4 2025.

Silo Pharma (SILO) Shares Issued (2023 - 2026) Analysis & Trends

Silo Pharma has reported Shares Issued for 4 years, with the latest figure at $71183.0 in Q1 2026.

Quarterly Shares Issued changed N/A year-over-year to $71183.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71183.0 (changed N/A YoY) and the FY2025 annual result came in at $522850.0, up 2188.18% from the prior year.
Shares Issued eased to $71183.0 in Q1 2026 per SILO's latest filing, from $522850.0 in the prior quarter.
Over five years, Shares Issued peaked at $522850.0 in Q4 2023 and troughed at $22850.0 in Q4 2024.
A 4-year average of $198197.2 and a median of $48891.5 in 2025 frame the typical range for Shares Issued.
The sharpest annual moves came in 2024 and 2025: Shares Issued plunged 95.63% in 2024, then surged 2188.18% in 2025.
Over 4 years, Shares Issued stood at $522850.0 in 2023, then slumped by 95.63% to $22850.0 in 2024, then soared by 2188.18% to $522850.0 in 2025, then plunged by 86.39% to $71183.0 in 2026.
According to Business Quant data, Shares Issued over the past three periods registered $71183.0, $522850.0, and $26600.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Silo Pharma	2.92 Mn	2.92 Mn	-	663,981.00

Download Data